Advertisement
Advertisement

KRYS

KRYS logo

Krystal Biotech, Inc. Common Stock

309.56
USD
Sponsored
-3.32
-1.06%
May 12, 13:39 UTC -4
Open

Krystal Biotech, Inc. Common Stock Profile

About

Krystal Biotech, Inc. is a gene therapy company. It engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. Krystal Biotech, Inc. is based in Pittsburgh, United States.

Info & Links

CEO

Krish S. Krishnan

Headquarters

2100 WHARTON STREET, SUITE 701
PITTSBURGH, PA 15203, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.krystalbio.com

Auditor

KPMG LLP

Share holders

4

Employees

295

Krystal Biotech, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

9.13B

Enterprise Value

8.63B

Enterprise Value/EBITDA(ttm)

51.41

Price to Earnings Ratio(ttm)

37.71

Price to Sales(ttm)

19.54

Price to Book(mrq)

6.14

Price to Cash(ytd)

35.44

Profitability

Gross Margin(ttm)

94.08%

Operating Margin(ttm)

52.64%

Profit Margin(ttm)

52.39%

Return on Equity(ttm)

18.69%

Return on Invested Capital(ttm)

18.50%

Return on Assets(ttm)

17.12%

Income Statement

Revenue(ttm)

389.13M

Revenue Per Share(ttm)

13.31

Gross Profit(ttm)

366.08M

EBITDA(ttm)3

167.85M

Net Income Available to Common(ttm)

204.83M

Diluted EPS(ttm)

6.85

Share Statistics

Beta (5Y Monthly)

0.54

52-Week Change

134.19%

S&P 500 52-Week Change

26.03%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

29.23M

Dividend Yield

0.00%

Float4

25.40M

% Held by Insiders

13.70%

% Held by Institutions

86.29%

Balance Sheet

Total Cash(mrq)

827.79M

Total Cash Per Share(mrq)

28.32

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

9.95%

Quick Ratio(mrq)

9.56%

Book Value Per Share(mrq)

41.78

Cash Flow

Operating Cash Flow Per Share(ytd)

6.71

Free Cash Flow(ytd)

189.35M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement